Detalles de la búsqueda
1.
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
J Transl Med
; 22(1): 242, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443899
2.
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Oncologist
; 27(6): e484-e493, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429394
3.
Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.
Oncologist
; 24(6): e251-e259, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30139835
4.
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).
Oncologist
; 24(6): e318-e326, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30846513
5.
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol
; 19(6): 799-811, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753703
6.
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.
Future Oncol
; 14(14): 1347-1354, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29774766
7.
HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
Int J Mol Sci
; 18(7)2017 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653974
8.
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer.
BMC Cancer
; 16: 312, 2016 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27179511
9.
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.
Lancet Oncol
; 15(12): 1379-88, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25439692
10.
Multiorgan failure caused by pembrolizumab and axitinib in a woman affected by metastatic clear cell renal cell carcinoma: A case report and literature review.
Medicine (Baltimore)
; 103(13): e37606, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552059
11.
Effects of sulfonylureas on tumor growth: a review of the literature.
Oncologist
; 18(10): 1118-25, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24043597
12.
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland.
J Cancer Surviv
; 17(6): 1847-1858, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35689003
13.
Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
J Immunother
; 46(1): 22-26, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36472582
14.
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study.
Eur J Cancer
; 167: 81-91, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35398759
15.
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.
Eur J Cancer
; 147: 120-127, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33647547
16.
A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients.
J Thorac Oncol
; 15(1): 80-90, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31622732
17.
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial.
Lung Cancer
; 134: 121-126, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319970
18.
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice.
Clin Pharmacol Ther
; 105(4): 994-1002, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30339275
19.
Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
Lung Cancer
; 60(2): 240-5, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18022729
20.
Second-line Treatment of Advanced Non-small Cell Lung Cancer Non-oncogene Addicted: New Treatment Algorithm in the Era of Novel Immunotherapy.
Curr Clin Pharmacol
; 13(2): 76-84, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29992894